SP
FBT icon

Stablepoint Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Stablepoint Partners’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
5,139
+210
+4% +$45.2K 0.18% 140
2026
Q1 		$990K Sell
4,929
-51
-1% -$10.5K 0.15% 159
2025
Q4 		$1.03M Buy
4,980
+108
+2% +$21.6K 0.16% 148
2025
Q3 		$874K Buy
4,872
+404
+9% +$68.8K 0.14% 159
2025
Q2 		$721K Buy
4,468
+130
+3% +$20.7K 0.12% 162
2025
Q1 		$738K Sell
4,338
-1,720
-28% -$299K 0.13% 157
2024
Q4 		$1.01M Buy
6,058
+226
+4% +$38.6K 0.18% 141
2024
Q3 		$1M Buy
5,832
+1,059
+22% +$175K 0.18% 138
2024
Q2 		$792K Buy
4,773
+2,638
+124% +$396K 0.15% 148
2024
Q1 		$328K Buy
2,135
+588
+38% +$89.7K 0.07% 207
2023
Q4 		$245K Buy
+1,547
New +$222K 0.06% 208

Other funds holding FBT

JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
OPAM
Ocean Park Asset Management Santa Monica, California $2.08B AUM 5.32% 1-Year Est. Return
QCIG
Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FEG
Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return
TCOO
Trust Company of Oklahoma Tulsa, Oklahoma $389M AUM 34.72% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IWM
Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Stablepoint Partners's FBT Position: Q2 2026 in Review

Stablepoint Partners increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 4.3% in Q2 2026, buying an estimated $45.2K and bringing the position to 5,139 shares worth $1.27M. The position accounts for 0.18% of the portfolio, ranked #140.

Stablepoint Partners first reported a position in FBT in Q4 2023 and has held it in 11 quarters since. 51 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Stablepoint Partners held 5,139 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.27M as of Q2 2026.
  • Stablepoint Partners bought 210 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $45.2K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.18% of Stablepoint Partners's portfolio in Q2 2026, its #140 holding.
  • Stablepoint Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 11 quarters since.
  • 51 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.